<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000512986">
  <TermName>ProMune</TermName>
  <TermPronunciation>(PROH-myoon)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of some types of cancer. It belongs to the family of drugs called biological response modifiers. Also called CpG 7909 and PF-3512676.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000718407" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ProMune&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000718406" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ProMune&quot;" language="es" id="_4"/>
  <SpanishTermName>ProMune</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de cáncer. Es un tipo de modificador de la respuesta biológica. También se llama CpG 7909 y PF-3512676.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2006-10-14</DateFirstPublished>
  <DateLastModified>2006-10-12</DateLastModified>
</GlossaryTerm>
